Identification of CAD candidate genes in GWAS loci and their expression in vascular cells[S]

Recent genome-wide association studies (GWAS) have identified 35 loci that significantly associate with coronary artery disease (CAD) susceptibility. The majority of the genes represented in these loci have not previously been studied in the context of atherosclerosis. To characterize the roles of these candidate genes in the vessel wall, we determined their expression levels in endothelial, smooth muscle, and macrophage cells isolated from healthy, prelesioned, and lesioned mouse aortas. We also performed expression quantitative locus (eQTL) mapping of these genes in human endothelial cells under control and proatherogenic conditions. Of the 57 genes studied, 31 were differentially expressed in one or more cell types in disease state in mice, and the expression levels of 8 were significantly associated with the CAD SNPs in human cells, 7 of which were also differentially expressed in mice. By integrating human and mouse results, we predict that PPAP2B, GALNT4, MAPKAPK5, TCTN1, SRR, SNF8, and ICAM1 play a causal role in the susceptibility to atherosclerosis through a role in the vasculature. Additionally, we highlight the genetic complexity of a subset of CAD loci through the differential expression of multiple candidate genes per locus and the involvement of genes that lie outside linkage disequilibrium blocks.

[1]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[2]  M. Reilly,et al.  Genetic Basis of Atherosclerosis: Insights From Mice and Humans , 2012, Circulation research.

[3]  M. Hollingsworth,et al.  Cloning of a Human UDP-N-Acetyl-α-d-Galactosamine:PolypeptideN-Acetylgalactosaminyltransferase That Complements Other GalNAc-Transferases in Complete O-Glycosylation of the MUC1 Tandem Repeat* , 1998, The Journal of Biological Chemistry.

[4]  W. Skarnes,et al.  Tectonic, a novel regulator of the Hedgehog pathway required for both activation and inhibition. , 2006, Genes & development.

[5]  Tsun-Po Yang,et al.  Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies , 2010, Bioinform..

[6]  D. Srivastava,et al.  Genetics of Human Cardiovascular Disease , 2012, Cell.

[7]  Asrar B. Malik,et al.  Lipid Phosphate Phosphatase 3 Stabilization of β-Catenin Induces Endothelial Cell Migration and Formation of Branching Point Structures , 2010, Molecular and Cellular Biology.

[8]  J. Roder,et al.  Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. , 2009, Human molecular genetics.

[9]  A. Marian PCSK9 as a Therapeutic Target in Atherosclerosis , 2010, Current atherosclerosis reports.

[10]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[11]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Thakker,et al.  Regulation of cell–cell interactions by phosphatidic acid phosphatase 2b/VCIP , 2003, The EMBO journal.

[13]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[14]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[15]  Aiqing He,et al.  Systems genetics analysis of gene-by-environment interactions in human cells. , 2010, American journal of human genetics.

[16]  K. Wary,et al.  Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand. , 2005, Biochemical and biophysical research communications.

[17]  K. Sakimura,et al.  Serine racemase is predominantly localized in neurons in mouse brain , 2008, The Journal of comparative neurology.

[18]  M. Farnier The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemia , 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[19]  James R. Springstead,et al.  Role of Phospholipid Oxidation Products in Atherosclerosis , 2012, Circulation research.

[20]  A. Brech,et al.  Vps22/EAP30 in ESCRT‐II Mediates Endosomal Sorting of Growth Factor and Chemokine Receptors Destined for Lysosomal Degradation , 2007, Traffic.

[21]  A. Morris,et al.  Lipid Phosphate Phosphatase 3 Negatively Regulates Smooth Muscle Cell Phenotypic Modulation to Limit Intimal Hyperplasia , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[23]  Silke Szymczak,et al.  Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility , 2010, PloS one.

[24]  M. Cybulsky,et al.  Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis , 2006, The Journal of experimental medicine.

[25]  Jiahuai Han,et al.  The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.

[26]  T. Natsume,et al.  The Kelch repeat protein KLHDC10 regulates oxidative stress-induced ASK1 activation by suppressing PP5. , 2012, Molecular cell.

[27]  John F. Peden,et al.  Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour , 2011, Human molecular genetics.

[28]  Tom R. Gaunt,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[29]  Simon C. Potter,et al.  Mapping cis- and trans-regulatory effects across multiple tissues in twins , 2012, Nature Genetics.

[30]  A. Stewart,et al.  Genes and coronary artery disease: where are we? , 2012, Journal of the American College of Cardiology.

[31]  Christian Gieger,et al.  A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium , 2009, Nature Genetics.

[32]  Roger A. Davis,et al.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ , 2004 .

[33]  A. Stanton,et al.  Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2) , 2009, Journal of Thrombosis and Thrombolysis.

[34]  B. Hierck,et al.  Primary cilia as biomechanical sensors in regulating endothelial function. , 2012, Differentiation; research in biological diversity.

[35]  Chong Shen,et al.  Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease , 2012, Nature Genetics.

[36]  H. Kang,et al.  Variance component model to account for sample structure in genome-wide association studies , 2010, Nature Genetics.

[37]  Christian Gieger,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[38]  Simon C. Potter,et al.  Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease , 2011, PLoS genetics.

[39]  A. Prat,et al.  Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice , 2012, Circulation.

[40]  L. Stevenson,et al.  Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. , 1988, The Journal of clinical investigation.

[41]  A. Shilatifard,et al.  Cloning and Characterization of the EAP30 Subunit of the ELL Complex That Confers Derepression of Transcription by RNA Polymerase II* , 1999, The Journal of Biological Chemistry.

[42]  T. Lehtimäki,et al.  Proprotein convertases in human atherosclerotic plaques: the overexpression of FURIN and its substrate cytokines BAFF and APRIL. , 2011, Atherosclerosis.

[43]  J. García-Verdugo,et al.  A Transition Zone Complex Regulates Mammalian Ciliogenesis and Ciliary Membrane Composition , 2011, Nature Genetics.

[44]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[45]  R. Collins,et al.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.

[46]  Jiahuai Han,et al.  A Novel Function of p38-Regulated/Activated Kinase in Endothelial Cell Migration and Tumor Angiogenesis , 2011, Molecular and Cellular Biology.

[47]  Roger A. Davis,et al.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. , 2004, The Journal of clinical investigation.

[48]  R Bailén Almorox,et al.  [Effect of a monoclonal antibody to PCSK9 on LDL cholesterol]. , 2012, Revista clinica espanola.